Department of Surgical Oncology, PO Box 30001, 9700 RB, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Am J Surg. 2010 Oct;200(4):446-53. doi: 10.1016/j.amjsurg.2009.12.006. Epub 2010 Apr 20.
High recurrence rates determine the dismal outcome in esophageal cancer. We reviewed our experiences and defined prognostic factors and patterns of recurrences after curatively intended transthoracic esophagectomy.
Between January 1991 and December 2005, 212 consecutive patients underwent a radical transthoracic esophagectomy with extended 2-field lymphadenectomy. Recurrence rates, survival, and prognostic factors were analyzed (minimal follow-up period, 2 y).
Radicality was obtained in 85.6%. The median follow-up period was 26.6 months. The overall recurrence rate at 1, 3, and 5 years was 28%, 44%, and 64%, respectively, and locoregional recurrence rate was 17%, 27%, and 43%, respectively. Overall survival rates, including postoperative deaths, were 45% and 34% at 3 and 5 years, respectively. pT stage and lymph node (LN) ratio greater than .20 were independent prognostic factors for survival and recurrences. Radicality was most prognostic for survival, and for N+ greater than 4 positive LN for recurrences.
Radicality and LN ratio are strong prognostic factors. High radicality and adequate nodal assessment are guaranteed by an extended transthoracic approach.
高复发率决定了食管癌的预后不良。我们回顾了我们的经验,并确定了根治性经胸食管癌切除术后的预后因素和复发模式。
1991 年 1 月至 2005 年 12 月期间,212 例连续患者接受了根治性经胸食管切除术和扩展的 2 野淋巴结清扫术。分析了复发率、生存率和预后因素(最小随访时间为 2 年)。
根治性手术率为 85.6%。中位随访时间为 26.6 个月。1、3 和 5 年的总体复发率分别为 28%、44%和 64%,局部区域复发率分别为 17%、27%和 43%。包括术后死亡在内的总生存率分别为 3 年和 5 年的 45%和 34%。pT 分期和淋巴结(LN)比例大于 0.20 是生存和复发的独立预后因素。根治性是生存的最重要预后因素,对于 N+大于 4 个阳性 LN 则是复发的最重要预后因素。
根治性和 LN 比例是强烈的预后因素。广泛的经胸入路可保证高度根治性和充分的淋巴结评估。